Hurricane preparedness can involve some extra considerations for those with hemophilia, says columnist Jennifer Lynne, who shares some tips.

Columnist Joe MacDonald describes his early adjustments to cope with the reality of his oldest son's hemophilia.

Certain immune markers in the blood may help predict ITI response among hemophilia A patients given immune tolerance ...

While packing for a move, the youngest son of columnist Cazandra Campos-MacDonald experiences a regular guest: joint pain.

Preventive treatment with Pfizer's Hympavzi can reduce bleeding rates in hemophilia A or B patients with inhibitors, new ...

Directly switching from Hemlibra to Mim8 was well tolerated in people with hemophilia A, with or without inhibitors, a study ...

Like many with hemophilia, columnist G Shellye Horowitz requires IV infusions of her medication — but the scars can raise some eyebrows.

Columnist G Shellye Horowitz struggles to find care for her gastrointestinal issues due to the shortage of medical providers ...

Hemophilia type A, sometimes called classic hemophilia, is the most common. It’s caused by a deficiency in FVIII. Hemophilia type B, also known as Christmas Disease, is the second-most common type. It ...

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her ...

Hemophilia is a rare disorder in which the blood doesn’t clot properly, resulting in the disease’s hallmark symptoms of bleeds — excessive bleeding that extends over a prolonged period of time — that ...

Hemophilia A treatment While there is no cure for hemophilia A, treatments are available to help manage symptoms, improve life expectancy, and reduce the risk of complications. Hemophilia A treatment ...